Abstract:The transition of a healthy tissue to a pre-malignant and subsequent malignant stage is typically characterized by a marked increase in extracellular fibrosis and collagen density. Such changes coincide with a significant increase in tissue stiffness as the tumor progresses. Despite the large body of work on endothelial cell changes in tumoral angiogenesis, little is known about the dynamic interactions of endothelial cells, perivascular cells, and the extracellular matrix in early-to-late cancers. Appreciating such interactions is crucial for understanding tumorigenesis and early tumor progression. To model the spectrum of vascular changes occurring on pre-tumoral and tumoral ecosystems, we developed an organ-on-a-chip model of biomimetic pericyte-supported capillaries with collagen having increasingly higher density, stiffness and discrete fibril microarchitectures. Briefly, 160-um channels were engineered using type I collagen that underwent fibrillogenesis at different temperatures (4, 16, 21, and 37oC). Thus, the microarchitecture and stiffness would vary from a soft reticular network (healthy/pre-cancerous vascular capillaries) to a stiff fibrillar mesh (fibrotic/tumoral vascular capillaries). We then seeded human umbilical vein endothelial cells (HUVECs) and mesenchymal stem cells (MSCs) in the collagen channels. After 48h, samples were fixed and stained for actin (cytoskeleton), NG2 (pericyte differentiation), and CD31 (endothelial cell junction), laminin, and cell anchorage system, imaged with a confocal microscope and analyzed with Imaris. In addition, we used a Nanostring panel with 770 genes related to the tumor microenvironment in healthy and fibrosis. Vascular capillaries engineered in contact with softer reticular collagen, consistent with a healthy ECM, showed more pericyte differentiation (p<0.05), inter-endothelial cell junctions (p<0.05), and effective barrier function. In contrast, stiffer fibrillar collagen, which is consistent with the characteristics of the fibrotic malignant extracellular microenvironment, was associated with cell migration outward the vessel, leakiness, and higher RNA expression of interleukin 8 (IL8), TP53, transforming growth factor beta, vimentin, and collagen III genes, thus suggesting a system that compatible with the spectrum of tumoral vasculature changes in cancer and pre-cancer lesions. When vessels were engineered without MSCs, those differences were drastically minimized, To further understand the mechanisms, HUVEC-perivascular cell adhesion was disrupted using silencing RNA for NOTCH3. Upon silencing NOTCH3, the morphology and function of vasculature were reestablished, pointing to a major role of perivascular cells in vascular changes in early tumors. Funding: NIDCR 1K01DE030484-01A1 to CMF R01DE026170, 3R01DE026170-03S1 and 3R01DE026170-03S2 to LEB Citation Format: Cristiane Franca, Avathamsa Athirasala, Emilios Dimitriadis, Jennifer Bays, Kenneth Yamada, Christopher Chen, Luiz E. Bertassoni. Modeling the spectrum of vascular changes occurring in healthy and early malignant cancers on a chip [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2024; Part 1 (Regular s); 2024 Apr 5-10; San Diego, CA. Philadelphia (PA): AACR; Cancer Res 2024;84(6_Suppl) nr 6894.

Increased PD-L1 Expression and IL-6 Secretion Characterize Human Lung Tumor-Derived Perivascular-Like Cells That Promote Vascular Leakage in a Perfusable Microvasculature Model.

Peritumoral CD90+CD73+ cells possess immunosuppressive features in human non-small cell lung cancer

Role of Tumor Pericytes in the Recruitment of Myeloid-Derived Suppressor Cells

An Insight into Perfusion Anisotropy within Solid Murine Lung Cancer Tumors

Tumor Associated CD90+ Mesenchymal Cells Are Chemoresistant and Immunosuppressive in Human Non-Small Cell Lung Cancer

Primary tumor-secreted VEGF induces vascular hyperpermeability in premetastatic lung via the occludin phosphorylation/ubiquitination pathway.

Abstract B029: Mapping the vascular walls of colorectal cancer

Assessment of PD-L1 and CD47 Expression Together with Tumor-Associated TILs in Resectable Early Stage NSCLC

Lung cancer cell-intrinsic IL-15 promotes cell migration and sensitizes murine lung tumors to anti-PD-L1 therapy

Tumor-induced peripheral immunosuppression promotes brain metastasis in patients with non-small cell lung cancer

Abstract 6894: Modeling the spectrum of vascular changes occurring in healthy and early malignant cancers on a chip

Massive PD-L1 and CD8 double positive TILs characterize an immunosuppressive microenvironment with high mutational burden in lung cancer

The Pan-tumor Vasculature Under the Transcriptomic Magnifying Glass

In Situ Overexpression of Matricellular Mechanical Proteins Demands Functional Immune Signature and Mitigates Non-Small Cell Lung Cancer Progression

Tissue-resident macrophages provide a pro-tumorigenic niche to early NSCLC cells

Lung tumor microphysiological system with 3D endothelium to evaluate modulators of T-cell migration

Characterization of the pleural microenvironment niche and cancer transition using single-cell RNA sequencing in EGFR-mutated lung cancer

Tumor-derived exosomal miR-3157-3p promotes angiogenesis, vascular permeability and metastasis by targeting TIMP/KLF2 in non-small cell lung cancer

Tumor-Activated Neutrophils Promote Lung Cancer Progression through the IL-8/PD-L1 Pathway

Characterisation of circulating tumor‐associated and immune cells in patients with advanced‐stage non‐small cell lung cancer

High Endothelial Venules Predict Response to PD-1 Inhibitors Combined with Anti-Angiogenesis Therapy in NSCLC